Tess Burleson - Net Worth and Insider Trading

Tess Burleson Net Worth

The estimated net worth of Tess Burleson is at least $246 dollars as of 2024-11-06. Tess Burleson is the Director of Salarius Pharmaceuticals Inc and owns about 160 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $246. Details can be seen in Tess Burleson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tess Burleson has not made any transactions after 2022-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Tess Burleson

To

Tess Burleson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tess Burleson owns 1 companies in total, including Salarius Pharmaceuticals Inc (SLRX) .

Click here to see the complete history of Tess Burleson’s form 4 insider trades.

Insider Ownership Summary of Tess Burleson

Ticker Comapny Transaction Date Type of Owner
SLRX Salarius Pharmaceuticals Inc 2022-06-07 director

Tess Burleson Latest Holdings Summary

Tess Burleson currently owns a total of 1 stock. Tess Burleson owns 160 shares of Salarius Pharmaceuticals Inc (SLRX) as of June 7, 2022, with a value of $246.

Latest Holdings of Tess Burleson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SLRX Salarius Pharmaceuticals Inc 2022-06-07 160 1.54 246

Holding Weightings of Tess Burleson


Tess Burleson Form 4 Trading Tracker

According to the SEC Form 4 filings, Tess Burleson has made a total of 2 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 138 shares on June 7, 2022, which cost Tess Burleson around $4,986.

Insider Trading History of Tess Burleson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tess Burleson Trading Performance

GuruFocus tracks the stock performance after each of Tess Burleson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tess Burleson is 8.87%. GuruFocus also compares Tess Burleson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tess Burleson within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tess Burleson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tess Burleson

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.72 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 16 LIMIT LIMIT LIMIT LIMIT LIMIT

Tess Burleson Ownership Network

Ownership Network List of Tess Burleson

No Data

Ownership Network Relation of Tess Burleson

Insider Network Chart

Tess Burleson Owned Company Details

What does Salarius Pharmaceuticals Inc do?

Who are the key executives at Salarius Pharmaceuticals Inc?

Tess Burleson is the director of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .

Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Salarius Pharmaceuticals Inc Insider Transactions

No Available Data

Tess Burleson Mailing Address

Above is the net worth, insider trading, and ownership report for Tess Burleson. You might contact Tess Burleson via mailing address: 2450 Holcome Blvd., Suite J-608, Houston Tx 77021.